Updates from ASH 2019 relating to the management of patients with acute myeloid leukemia (AML) and selected B-cell lymphomas

On February 6th and 7th we will broadcast the plenary sessions live from the Debate. Our expert faculties will discuss the importance of recent data including data presented during the American Society of Hematology (ASH) 2019 congress relating to the management of patients with acute myeloid leukemia, chronic lymphocytic leukemia, B-cell lymphomas and multiple myeloma. A focus will be on how these new data could impact current clinical practice.

Learning objective:

After participating in this session delegates should be able to:

• Summarise data presented during ASH 2019 relating to the management of patients with AML, WM and MCL

Faculty:

• Georg Hess (Germany)
• Charles Craddock (UK)
• Simon Rule (UK)
• Steve Treon (USA)
• Christian Buske (Germany)